183 related articles for article (PubMed ID: 24621590)
1. Serum thymidine kinase activity: analytical performance, age-related reference ranges and validation in chronic lymphocytic leukemia.
Szánthó E; Bhattoa HP; Csobán M; Antal-Szalmás P; Újfalusi A; Kappelmayer J; Hevessy Z
PLoS One; 2014; 9(3):e91647. PubMed ID: 24621590
[TBL] [Abstract][Full Text] [Related]
2. Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors.
Xu W; Cao X; Miao KR; Qiao C; Wu YJ; Liu Q; Fan L; Li JY
Int J Hematol; 2009 Sep; 90(2):205-211. PubMed ID: 19629630
[TBL] [Abstract][Full Text] [Related]
3. [Lipoprotein lipase and serum thymidine kinase level in chronic lymphocytic leukemia and their correlations with other prognostic factors].
Xu W; Shen QD; Yu H; Qiao C; Wu YJ; Liu Q; Zhu DX; Miao KR; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):8-12. PubMed ID: 19563027
[TBL] [Abstract][Full Text] [Related]
4. High serum thymidine kinase 1 level predicts poorer survival in patients with chronic lymphocytic leukemia.
Konoplev SN; Fritsche HA; O'Brien S; Wierda WG; Keating MJ; Gornet TG; St Romain S; Wang X; Inamdar K; Johnson MR; Medeiros LJ; Bueso-Ramos CE
Am J Clin Pathol; 2010 Sep; 134(3):472-7. PubMed ID: 20716805
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia.
Hallek M; Langenmayer I; Nerl C; Knauf W; Dietzfelbinger H; Adorf D; Ostwald M; Busch R; Kuhn-Hallek I; Thiel E; Emmerich B
Blood; 1999 Mar; 93(5):1732-7. PubMed ID: 10029603
[TBL] [Abstract][Full Text] [Related]
6. Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels.
Rivkina A; Vitols G; Murovska M; Lejniece S
Exp Oncol; 2011 Jun; 33(2):99-103. PubMed ID: 21716207
[TBL] [Abstract][Full Text] [Related]
7. Elevated IL-17A and IL-22 regulate expression of inducible CD38 and Zap-70 in chronic lymphocytic leukemia.
Kouzegaran S; Siroosbakht S; Farsad BF; Rezakhaniha B; Dormanesh B; Behnod V; Tanha AS
Cytometry B Clin Cytom; 2018 Jan; 94(1):143-147. PubMed ID: 27718514
[TBL] [Abstract][Full Text] [Related]
8. The activity of atorvastatin and rosiglitazone on CD38, ZAP70 and apoptosis in lymphocytes of B-cell chronic lymphocytic leukemia in vitro.
Yavasoglu I; Sargin G; Kadikoylu G; Karul A; Bolaman Z
Med Oncol; 2013; 30(3):603. PubMed ID: 23686733
[TBL] [Abstract][Full Text] [Related]
9. Determination of HLA-G Expression and Evaluation of Its Role as a Prognostic Factor in Chronic Lymphocytic Leukemia.
Ozet G; Falay M; Dagdas S; Ceran F
J Clin Lab Anal; 2016 Sep; 30(5):399-403. PubMed ID: 26303056
[TBL] [Abstract][Full Text] [Related]
10. THE PROGNOSTIC SIGNIFICANCE OF COMBAIND EXPRESSION OF ZAP-70 AND CD38 IN CHRONIC LYMPHOCYTIC LEUKEMIA.
Kirtava T; Vatsadze T; Azrmaiparashili E; Ghirdaladze D
Georgian Med News; 2017 Jun; (267):12-16. PubMed ID: 28726646
[TBL] [Abstract][Full Text] [Related]
11. Long intergenic non-coding RNA-p21 is associated with poor prognosis in chronic lymphocytic leukemia.
Abo Elwafa R; Abd Elrahman A; Ghallab O
Clin Transl Oncol; 2021 Jan; 23(1):92-99. PubMed ID: 32468342
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia.
Hus I; Podhorecka M; Bojarska-Junak A; Roliński J; Schmitt M; Sieklucka M; Wasik-Szczepanek E; Dmoszyńska A
Ann Oncol; 2006 Apr; 17(4):683-90. PubMed ID: 16524977
[TBL] [Abstract][Full Text] [Related]
13. Presence of serum antinuclear antibodies correlating unfavorable overall survival in patients with chronic lymphocytic leukemia.
Sun Q; Wang L; Zhu HY; Miao Y; Wu W; Liang JH; Cao L; Xia Y; Wu JZ; Wang Y; Wang R; Fan L; Xu W; Li JY
Chin Med J (Engl); 2019 Mar; 132(5):525-533. PubMed ID: 30741830
[TBL] [Abstract][Full Text] [Related]
14. CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Gooden CE; Jones P; Bates R; Shallenberger WM; Surti U; Swerdlow SH; Roth CG
Cytometry B Clin Cytom; 2018 Jan; 94(1):129-135. PubMed ID: 27221715
[TBL] [Abstract][Full Text] [Related]
15. CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells.
Damle RN; Temburni S; Calissano C; Yancopoulos S; Banapour T; Sison C; Allen SL; Rai KR; Chiorazzi N
Blood; 2007 Nov; 110(9):3352-9. PubMed ID: 17684154
[TBL] [Abstract][Full Text] [Related]
16. CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia.
Hayat A; O'Brien D; O'Rourke P; McGuckin S; Fitzgerald T; Conneally E; Browne PV; McCann SR; Lawler MP; Vandenberghe E
Leuk Lymphoma; 2006 Nov; 47(11):2371-9. PubMed ID: 17107912
[TBL] [Abstract][Full Text] [Related]
17. Multi-drug resistance mediated by P-glycoprotein overexpression is not correlated with ZAP-70/CD38 expression in B-cell chronic lymphocytic leukemia.
Guillaume N; Gouilleux-Gruart V; Claisse JF; Troussard X; Lepelley P; Damaj G; Royer B; Garidi R; Lefrere JJ
Leuk Lymphoma; 2007 Aug; 48(8):1556-60. PubMed ID: 17701587
[TBL] [Abstract][Full Text] [Related]
18. [PD-1/PD-L1 expression and its implications in patients with chronic lymphocytic leukemia].
Li JH; Pang NN; Zhang ZH; Zhang R; Chen G; Qu JH
Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):198-203. PubMed ID: 28395442
[No Abstract] [Full Text] [Related]
19. Overexpression of human thymidine kinase mRNA without corresponding enzymatic activity in patients with chronic lymphatic leukemia.
Kristensen T; Jensen HK; Munch-Petersen B
Leuk Res; 1994 Nov; 18(11):861-6. PubMed ID: 7967713
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemia.
Alonci A; Allegra A; Bellomo G; D'Angelo A; Penna G; Cannavò A; Musolino C
Med Oncol; 2010 Dec; 27(4):1336-9. PubMed ID: 20013319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
